Research and development of mAb drugs in China: a look from policy perspectives

• Main Authors: Rong Jiang (Author), Yuanyuan Sun (Author), Carolina Ung (Author), Xinyue Dong (Author), Xiangjun Kong (Author), Yuanjia Hu (Author), Rong Shao (Author)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2019-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Monoclonal antibody (mAb) drugs are increasingly important for the pharmaceutical industry across the globe. In China, mAb drug developments face many challenges. Multiple policies have been implemented recently to reinforce support in various areas. This study aims to investigate the la...